Skip to content

A Retrospective Analysis of Initial Treatment Strategies for Hypopharyngeal Carcinoma Based on Real-World Data: Comparing Survival and Prognosis between Radical Surgery and Concurrent Chemoradiotherapy in Patients Stratified by Different TNM Staging Subgroups.

A Retrospective Analysis of Initial Treatment Strategies for Hypopharyngeal Carcinoma Based on Real-World Data: Comparing Survival and Prognosis between Radical Surgery and Concurrent Chemoradiotherapy in Patients Stratified by Different TNM Staging Subgroups.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600120367
Enrollment
Unknown
Registered
2026-03-12
Start date
2026-03-12
Completion date
Unknown
Last updated
2026-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypopharyngeal carcinoma

Interventions

Case group:None

Sponsors

The first affiliated hostipal of nanchang university
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Patients diagnosed with hypopharyngeal carcinoma at The First Affiliated Hospital of Nanchang University between January 2014 and January 2024. 2.Histologically confirmed hypopharyngeal squamous cell carcinoma. 3.Clinical stage III, IVA, or IVB (according to the 8th edition AJCC/UICC staging system). 4.Received radical surgery or concurrent chemoradiotherapy as initial treatment as defined above. 5.Complete baseline clinical, pathological, and staging data available. 6.Post-treatment follow-up duration >= 6 months (unless an event occurred within 6 months).

Exclusion criteria

Exclusion criteria: 1.Presence of distant metastasis. 2.Received non-radical treatment or palliative treatment alone. 3.Presence of a second primary cancer in the head and neck region. 4.Critically missing medical records, making accurate staging or efficacy evaluation impossible.

Design outcomes

Primary

MeasureTime frame
Progression-Free Survival (PFS);Overall Survival (OS);Disease-Specific Survival (DSS);

Countries

China

Contacts

Public Contactyanan liu

The first affiliated hostipal of nanchang university

liuyanan1105@163.com+86 791 88692519

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 20, 2026